flow semaglutide clinical trial in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled FLOW Trial: Semaglutide Lowers Risk

In response to the rampant smuggling of GLP-1 drugs into Taiwan, FDA Deputy Director-General Wang Te-yuan () stated that the illegal sources of slimming injections mainly fall into two categories: those carried into the country by travelers and those purchased online

Eli Lillys new experimental weight loss drug retatrutide showed the greatest weight loss in a medication trial to date

Journal of Child and Adolescent Psychopharmacology, 26 (9), 774783

Patients should inquire about their individualized treatment goals, including whether mucosal healing has been achieved, current inflammatory marker levels, and the appropriateness of their existing IBD regimen

Like Ozempic, it is approved for adults with type 2 diabetes to help lower blood sugar

Real-world studies suggest gastrointestinal side effects particularly nausea and digestive discomfort are among the leading reasons people stop treatment, alongside cost